COCRYSTAL PHARMA INC - COM (COCP)

CUSIP: 19188J300

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
4,495,313
Share change
+1,049,939
Total reported value
$3,192,000
Price per share
$0.71
Number of holders
21
Value change
+$1,132,523
Number of buys
15
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 19188J300?
CUSIP 19188J300 identifies COCP - COCRYSTAL PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of COCRYSTAL PHARMA INC - COM (COCP) as of Q1 2020

As of 31 Mar 2020, COCRYSTAL PHARMA INC - COM (COCP) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,495,313 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, MORGAN STANLEY, SABBY MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, ROYAL BANK OF CANADA, EMORY UNIVERSITY, Parallel Advisors, LLC, BANK OF AMERICA CORP /DE/, and Verition Fund Management LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.